Soleno Therapeutics
SLNO
SLNO
76 hedge funds and large institutions have $1.27B invested in Soleno Therapeutics in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
38% less call options, than puts
Call options by funds: $2.46M | Put options by funds: $3.98M
100.07% less ownership
Funds ownership: 203.22% → 103.15% (-100%)
Holders
76
Holding in Top 10
7
Calls
$2.46M
Puts
$3.98M
Top Buyers
| 1 | +$210M | |
| 2 | +$99.2M | |
| 3 | +$36.8M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$31.6M |
| 5 |
CG
Carlyle Group
Washington,
District of Columbia
|
+$22.7M |
Top Sellers
| 1 | -$36.6M | |
| 2 | -$33.7M | |
| 3 | -$11.9M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$9.59M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$8.97M |